EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Balchem's enterprise value is $5,437.3 Mil.
Balchem's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was $236.9 Mil. Therefore, Balchem's EV-to-EBITDA for today is 22.95.
The historical rank and industry rank for Balchem's EV-to-EBITDA or its related term are showing as below:
BCPC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 13.97 Med: 22.54 Max: 31.86
Current: 22.95
During the past 13 years, the highest EV-to-EBITDA of Balchem was 31.86. The lowest was 13.97. And the median was 22.54.
BCPC's EV-to-EBITDA is ranked worse than 65.63% of 1280
companies
in the Chemicals industry
Industry Median: 14.18
vs BCPC: 22.95
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Balchem EV-to-EBITDA Historical Data
The historical data trend for Balchem's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Balchem's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Balchem's EV-to-EBITDA Distribution in the Chemicals Industry
For the Chemicals industry and Basic Materials sector, Balchem's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Balchem's EV-to-EBITDA falls into.
Balchem's current Enterprise Value is $5,437.3 Mil.
Balchem's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $236.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Balchem (NAS:BCPC) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Balchem's share price for today is $162.96.
Balchem's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.170.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Thank you for viewing the detailed overview of Balchem's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BCPC has been successfully added to your 